Home › Biosimilar copies of blockbuster drug launch in major EU markets
 

Keywords :   


Biosimilar copies of blockbuster drug launch in major EU markets

2015-02-25 12:59:55| Biotech - Topix.net

Cheap versions of a top-selling drug for rheumatoid arthritis and Crohn's disease are being launched across major European markets in an important advance for a new type of medicines known as biosimilars. The products from South Korean firm Celltrion and its partners Hospira and Mundipharma will compete with Remicade, the original branded drug from Johnson & Johnson and Merck & Co.

Tags: major drug copies markets

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.10Google goes nuclear to power AI data centres
15.10Would Donald Trumps taxes on trade hurt US consumers?
15.10Atlantic Tropical Weather Outlook
15.10Eastern North Pacific Tropical Weather Outlook
15.10African nations race to put satellites in space
15.10American equal pay icon Lilly Ledbetter dies aged 86
14.10All Printing Resources and Omet to host Fall Technology Summit
14.10Farmer sentenced to prison in cattle theft and bankruptcy fraud scheme
More »